Immunophenotype of Tumor Cells
| Patient . | CD19 . | sIg . | CD5 . | CD22 . | CD23 . | CD38 . | |
|---|---|---|---|---|---|---|---|
| % . | Type . | ||||||
| PAI | 80 | 78 | MGκ++ | 86 | 47 | 37 | ND |
| BLO | 88 | 73 | Mλ++ | 1 | 82 | 46 | 0 |
| BAR | 16 | 19 | MGλ* | ND | ND | ND | ND |
| SAM | 48 | 48 | MGκ++ | 13 | 48 | 44 | 22 |
| LAR | 73 | 67 | MGκ++ | 20 | 34 | 0 | 6 |
| Patient . | CD19 . | sIg . | CD5 . | CD22 . | CD23 . | CD38 . | |
|---|---|---|---|---|---|---|---|
| % . | Type . | ||||||
| PAI | 80 | 78 | MGκ++ | 86 | 47 | 37 | ND |
| BLO | 88 | 73 | Mλ++ | 1 | 82 | 46 | 0 |
| BAR | 16 | 19 | MGλ* | ND | ND | ND | ND |
| SAM | 48 | 48 | MGκ++ | 13 | 48 | 44 | 22 |
| LAR | 73 | 67 | MGκ++ | 20 | 34 | 0 | 6 |
Tumor cells were obtained from blood, except for patient BAR in whom a bone marrow aspirate was analyzed.
Cytoplasmic Ig.